The Blood-Brain Barrier in Cortical Multiple Sclerosis Lesions

The blood-brain barrier (BBB) is composed mainly of specialized endothelial cells characterized by the presence of intercellular tight junctions. Additionally, perivascular cells, astrocytes, and surrounding basement membranes determine BBB integrity. BBB disruption is an early phenomenon in the formation of new white matter multiple sclerosis (MS) lesions; however, knowledge of the extent of BBB changes in gray matter MS lesions is lacking. Here, we studied several markers for BBB integrity in well-characterized brain tissue of patients with MS. Plasma protein leakage was enhanced in white matter lesions compared with that in normal-appearing white matter, whereas plasma protein leakage was absent in gray matter lesions. White matter lesions showed irregular basement membranes and parenchymal depositions of collagen type IV, whereas purely gray matter lesions lacked basement membrane alterations. Similarly, we observed no evidence for astrogliosis and tight junction changes in cortical MS lesions. Although BBB dysfunction is a common feature of white matter MS lesions, cortical MS lesions lack markers for BBB disruption or astrogliosis. Our data may indicate that BBB breakdown is not a critical event in the formation of gray matter MS lesions.

[1]  L. Bö,et al.  Extensive extracellular matrix depositions in active multiple sclerosis lesions , 2006, Neurobiology of Disease.

[2]  J. Geurts,et al.  Grey matter pathology in multiple sclerosis , 2006, Acta neurologica Scandinavica. Supplementum.

[3]  E. Frohman,et al.  Multiple sclerosis--the plaque and its pathogenesis. , 2006, The New England journal of medicine.

[4]  F. Barkhof,et al.  Blood–brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis , 2005, Neurobiology of Disease.

[5]  Roberto Mutani,et al.  Grey Matter Pathology in Multiple Sclerosis , 2005, Journal of neuropathology and experimental neurology.

[6]  Hans Lassmann,et al.  Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.

[7]  L. Bö,et al.  Basement Membrane Proteins in Multiple Sclerosis-Associated Inflammatory Cuffs: Potential Role in Influx and Transport of Leukocytes , 2005, Journal of neuropathology and experimental neurology.

[8]  M. Nedergaard,et al.  The blood–brain barrier: an overview Structure, regulation, and clinical implications , 2004, Neurobiology of Disease.

[9]  F. Barkhof,et al.  Magnetic resonance imaging as a tool to examine the neuropathology of multiple sclerosis , 2004, Neuropathology and applied neurobiology.

[10]  M. Barnett,et al.  Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion , 2004, Annals of neurology.

[11]  C. Brosnan,et al.  Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis , 2004, Acta Neuropathologica.

[12]  S. McQuaid,et al.  Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood–brain barrier leakage and active demyelination , 2003, The Journal of pathology.

[13]  B D Trapp,et al.  Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration , 2003, Multiple sclerosis.

[14]  B. Trapp,et al.  Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients , 2003, Journal of neuropathology and experimental neurology.

[15]  M. El-Sabaawi Breakdown of Will , 2002 .

[16]  Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. , 2002, Brain pathology.

[17]  B. Trapp,et al.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.

[18]  F Barkhof,et al.  Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. , 2001, Brain : a journal of neurology.

[19]  Ludwin Sk,et al.  The neuropathology of multiple sclerosis. , 2000 .

[20]  C. D. DE GROOT,et al.  Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS , 2000, Neuropathology and applied neurobiology.

[21]  P. Valk,et al.  Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. , 2000 .

[22]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[23]  D D Breimer,et al.  The blood-brain barrier in neuroinflammatory diseases. , 1997, Pharmacological reviews.

[24]  M Filippi,et al.  Magnetic resonance imaging in the differential diagnosis and monitoring of the treatment of multiple sclerosis , 1996, Current opinion in neurology.

[25]  J. Prineas,et al.  Blood‐Brain Barrier Abnormalities in Longstanding Multiple Sclerosis Lesions. An Immunohistochemical Study , 1994, Journal of neuropathology and experimental neurology.

[26]  B. Trapp,et al.  Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions , 1994, Journal of Neuroimmunology.

[27]  M. Esiri,et al.  Blood-brain barrier damage in acute multiple sclerosis plaques. An immunocytological study. , 1991, Brain : a journal of neurology.

[28]  M. Esiri,et al.  Immunocytochemical study of macrophages and microglial cells and extracellular matrix components in human CNS disease 2. Non-neoplastic diseases , 1991, Journal of the Neurological Sciences.

[29]  B E Kendall,et al.  Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. , 1990, Brain : a journal of neurology.

[30]  D. McFarlin,et al.  Astrocytes: auxiliary cells for immune responses in the central nervous system? , 1990, Immunology today.

[31]  D. MacManus,et al.  EARLY LESION OF MULTIPLE SCLEROSIS , 1988, The Lancet.

[32]  F. Roncaroli,et al.  Neuropathology of multiple sclerosis , 2012 .

[33]  J. Becker Letter: Garlic pyelography. , 1973, Lancet.